This research provides a comprehensive analysis of pulmonary hypertension (PH), covering its definition, epidemiology, and progression to highlight its clinical significance. It explores the latest updates in the PH classification and diagnostic criteria, emphasizing innovative risk stratification strategies and targeted treatments like combination therapies and novel agents such as Sotatercept. Tailored approaches for various PH subgroups, including those associated with left heart disease...